The Living Laboratory for Precision Medicine, announced in June 2020 as one of the seven successful bids to wave 1 of the UK Research and Innovation Strength in Places Fund (SiPF), brings together a collaboration of partners to address the biggest challenge currently facing precision medicine: the adoption of healthcare innovations into clinical practice for the benefit of patients.
The £38m government funding provided through UK Research and Innovation’s flagship Strength in Places Fund is part of a £90m investment to create the Living Laboratory, building on Glasgow's existing leadership and infrastructure in precision medicine.
The Living Laboratory will realise the full potential and benefit of precision medicine, cementing Glasgow as a global leader. The development of precision medicine innovations and their adoption into healthcare will deliver savings for the NHS, improve health outcomes and drive economic development in Govan, Glasgow, across Scotland and beyond.
What is precision medicine?
Precision Medicine is a new generation of healthcare delivery which signifies a movement away from a one-size-fits-all approach to medical care, tailoring medical diagnosis and treatment to the individual characteristics of patients. Through the development of cutting-edge tools and innovations such as medical imaging, genomics and artificial intelligence, precision medicine can be used to help treat people quickly and more successfully whilst avoiding unnecessary side effects from treatments that may not be effective.
The Living Laboratory offers a vibrant and supportive ecosystem that facilitates a ‘triple helix’ partnership between academia, industry and the NHS. As part of Glasgow’s award-winning precision medicine industry cluster, the Living Laboratory expands upon existing expertise, leadership and clinical infrastructure and accelerates the benefits of these strengths.
Facilitating a collaborative and dynamic environment, integrated within the Queen Elizabeth University Hospital, the Living Laboratory enables the co-development of ideas and innovations between industry, academia and healthcare to deliver substantial savings for the NHS, support companies to develop and commercialise and attract new precision medicine industry to Govan and Glasgow, creating new jobs, skills development opportunities and stimulating economic growth.
What is a Living Laboratory?
A Living Laboratory is an open innovation research environment that supports a co-development approach to design, develop and validate innovations, services and solutions. Using a collaborative and user centric approach, Living Laboratories create solutions for real-life problems.
“The Living laboratory is an opportunity to capture the health challenges in Glasgow and deploy research expertise to address particular local challenges. The Glasgow bid has really strong partnerships, the research is great, the challenges are very clear, it all comes together in a phenomenally good project which we are delighted to support”.
Mr David Sweeney, Executive Chair, UKRI
This partnership with industry brings funding expertise, capabilities and capacity to move from an idea, and a principle, into a product that can be delivered to the patient. The partnership between Glasgow and NHSGGC goes all the way back to Lister and McCune, and many of the approaches to modern medicine started in this part of the world".
Professor John Brown CBE, Chair of NHSGGC